Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
We developed an amorphous solid dispersion (ASD) of the poorly water-soluble molecule niclosamide that achieved a more than two-fold increase in bioavailability. Notably, this niclosamide ASD formulation increased the apparent drug solubility about 60-fold relative to the crystalline material due to...
Prif Awduron: | Miguel O. Jara, Zachary N. Warnken, Robert O. Williams |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
MDPI AG
2021-01-01
|
Cyfres: | Pharmaceutics |
Pynciau: | |
Mynediad Ar-lein: | https://www.mdpi.com/1999-4923/13/1/97 |
Eitemau Tebyg
-
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
gan: Miguel O. Jara, et al.
Cyhoeddwyd: (2022-11-01) -
Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions
gan: Marius Monschke, et al.
Cyhoeddwyd: (2020-06-01) -
Influence of Carbamazepine Dihydrate on the Preparation of Amorphous Solid Dispersions by Hot Melt Extrusion
gan: Xiangyu Ma, et al.
Cyhoeddwyd: (2020-04-01) -
The applications of machine learning to predict the forming of chemically stable amorphous solid dispersions prepared by hot-melt extrusion
gan: Junhuang Jiang, et al.
Cyhoeddwyd: (2023-12-01) -
Composition and Technology Development for Obtaining Amorphous Solid Dispersion of Ebastine by Hot Melt Extrusion to Increase Dissolution Rate
gan: K. A. Gusev, et al.
Cyhoeddwyd: (2023-12-01)